The Sequencing and Genomic Technologies Core Facility
will be closed December 26 - January 2.

Sequencing and Genomic Technologies (SGT) is a basic science research core affiliated with the Duke Cancer Institute (DCI) that offers a full range of state-of-the-art genomic services. For answers to common questions, please visit our Frequently Asked Questions page.

Associate Director Devi Swain Lenz is available for project consultations.

News & Announcements